New study aims to uncover clues about bone cancer relapse survival

NCT ID NCT06017518

Recruiting now Knowledge-focused Sponsor: Istituto Ortopedico Rizzoli Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This observational study is tracking 150 people whose high-grade osteosarcoma has come back near where it started. Researchers want to find out what factors affect how long people live after this type of relapse. The study will look at past and future cases to gather information that could help guide better care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand what influences survival after osteosarcoma returns near the original site, potentially guiding more personalized follow-up and treatment.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results depend on past medical records and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteosarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OSTEOSARCOMA

Contacts and locations

Locations

Azienda Ospedaliero-Universitaria Pisana
RECRUITING

Pisa, PI, 56126, Italy
IRCCS Istituto Ortopedico Rizzoli
RECRUITING

Bologna, BO, 40136, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.